Skip to main content
European Commission logo print header

Antibiotic targeting of wolbachia endosymbiotic bacteria as a new approach to the treatment of filarial infection and disease

Objectif

Wolbachia are symbiotic endobacteria in filarial nematodes that have recently emerged as targets for an improved chemotherapy of filariasis by tetracycline antibiotics, with the potential to close the gaps left open in current mass treatment programs. The purposes of this project are i) to obtain the optimal regimen with anti-Wolbachia antibiotics leading to Wolbachia depletion and sterilization or killing of adult worms in human filariasis (lymphatic filariasis, loiasis and onchocerciasis); ii) to analyse the role of Wolbachia in inflammatory processes which lead to disease manifestations (acute episodes of lymphangitis); iii) to investigate the role of Wolbachia release by microfilaricidal therapy in the induction of drug side effects. In their combination, the studies will allow to assess the role of Wolbachia in pathogenesis and as targets for the long-needed for sustained interruption of transmission.

Thème(s)

Data not available

Appel à propositions

Data not available

Régime de financement

CSC - Cost-sharing contracts

Coordinateur

UNIVERSITY OF BONN MEDICAL CENTER
Contribution de l’UE
Aucune donnée
Adresse
Sigmund-Freud-Strasse 25
53105 BONN
Allemagne

Voir sur la carte

Coût total
Aucune donnée

Participants (6)